22980

544135

MUKKA

img img img img
No Data Available

MUKKA PROTEINS LIMITED Share Price Update

As of the latest trading session, MUKKA PROTEINS LIMITED is trading at ₹24.7, up by ₹0.11 or 0.44% from its previous close. The stock has moved between ₹24.22 and ₹25.10 today. Over the past year, the stock has delivered a return of -18.41%. In the last month, it has returned 14.90%.

MUKKA PROTEINS LIMITED performance

Today’s low Today’s high
₹ 24.22 ₹ 25.10
₹ 24.63
52 week low 52 week high
₹ 18.27 ₹ 32.80
₹ 24.63
Open Price ₹ 24.60
Prev. Close ₹ 24.59
Volume (Shares) 376308.00
Total traded value ₹ 92.68
Upper Circuit ₹ 29.50
Lower Circuit ₹ 19.68
info

Investment Returns

Over 1 Month 14.90% Over 3 Months -0.92% Over 6 Months 1.36% Over 1 Year -18.41%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

MUKKA PROTEINS LIMITED fundamentals


  • Market cap (Cr) 738.90
  • P/E Ratio (TTM) 20.15
  • Beta 0.89
  • Book Value / share 13.64
  • Return on equity 10.83%
  • EPS (TTM) 1.22
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 18.76
info icon alternate text
  • Market cap (Cr) 741.60
  • P/E Ratio (TTM) 20.15
  • Beta 0.85
  • Book Value / share 13.64
  • Return on equity 10.83%
  • EPS (TTM) 1.22
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 18.76
info icon alternate text

MUKKA PROTEINS LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 538.75
Operating Expense 540.87
Net Profit 18.76
Net Profit Margin (%) 3.48
Earnings Per Share (EPS) 0.63
EBITDA 39.83
Effective Tax Rate (%) 23.64
Particulars SEP 2025 (Values in Cr)
Revenue 216.04
Operating Expense 221.92
Net Profit 3.61
Net Profit Margin (%) 1.67
Earnings Per Share (EPS) 0.12
EBITDA 19.39
Effective Tax Rate (%) 37.86
Particulars JUN 2025 (Values in Cr)
Revenue 129.90
Operating Expense 136.84
Net Profit 1.14
Net Profit Margin (%) 0.87
Earnings Per Share (EPS) 0.04
EBITDA 13.51
Effective Tax Rate (%) 36.66
Particulars MAR 2025 (Values in Cr)
Revenue 315.99
Operating Expense 312.30
Net Profit 13.09
Net Profit Margin (%) 4.14
Earnings Per Share (EPS) 0.43
EBITDA 27.33
Effective Tax Rate (%) 23.27
Particulars DEC 2024 (Values in Cr)
Revenue 279.99
Operating Expense 261.78
Net Profit 25.10
Net Profit Margin (%) 8.96
Earnings Per Share (EPS) 0.84
EBITDA 43.19
Effective Tax Rate (%) 20.79
Particulars MAR 2025 (Values in Cr)
Revenue 860.35
Operating Expense 850.82
Net Profit 41.68
Net Profit Margin (%) 4.84
Earnings Per Share (EPS) 1.39
EBITDA 92.77
Effective Tax Rate (%) 20.73
Particulars MAR 2024 (Values in Cr)
Revenue 1230.82
Operating Expense 1216.97
Net Profit 62.76
Net Profit Margin (%) 5.09
Earnings Per Share (EPS) 2.78
EBITDA 101.46
Effective Tax Rate (%) 12.40
Particulars MAR 2023 (Values in Cr)
Revenue 1045.64
Operating Expense 1020.17
Net Profit 39.42
Net Profit Margin (%) 3.76
Earnings Per Share (EPS) 1.79
EBITDA 74.55
Effective Tax Rate (%) 28.43
Particulars MAR 2022 (Values in Cr)
Revenue 692.89
Operating Expense 672.43
Net Profit 19.82
Net Profit Margin (%) 2.86
Earnings Per Share (EPS) 0.90
EBITDA 31.91
Effective Tax Rate (%) 29.71
Particulars MAR 2021 (Values in Cr)
Revenue 536.25
Operating Expense 539.34
Net Profit 4.61
Net Profit Margin (%) 0.85
Earnings Per Share (EPS) 0.21
EBITDA 9.05
Effective Tax Rate (%) 23.92
Particulars MAR 2025 (Values in Cr)
Book Value / Share 14.69
ROE % 11.50
ROCE % 11.75
Total Debt to Total Equity 0.98
EBITDA Margin 11.04
Particulars MAR 2024 (Values in Cr)
Book Value / Share 13.20
ROE % 27.33
ROCE % 19.15
Total Debt to Total Equity 1.15
EBITDA Margin 9.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 6.72
ROE % 38.62
ROCE % 24.01
Total Debt to Total Equity 1.77
EBITDA Margin 8.01
Particulars MAR 2022 (Values in Cr)
Book Value / Share 4.47
ROE % 31.32
ROCE % 18.20
Total Debt to Total Equity 2.03
EBITDA Margin 7.04
Particulars MAR 2021 (Values in Cr)
Book Value / Share 1209.53
ROE % 12.53
ROCE % 9.06
Total Debt to Total Equity 2.44
EBITDA Margin 4.58
Particulars MAR 2025 (Values in Cr)
Book Value / Share 13.48
ROE % 10.83
ROCE % 11.41
Total Debt to Total Equity 0.97
EBITDA Margin 10.46
Particulars MAR 2024 (Values in Cr)
Book Value / Share 12.17
ROE % 25.78
ROCE % 18.08
Total Debt to Total Equity 1.17
EBITDA Margin 8.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 5.53
ROE % 38.66
ROCE % 23.13
Total Debt to Total Equity 1.96
EBITDA Margin 6.99
Particulars MAR 2022 (Values in Cr)
Book Value / Share 3.74
ROE % 27.31
ROCE % 16.76
Total Debt to Total Equity 1.99
EBITDA Margin 5.81
Particulars MAR 2021 (Values in Cr)
Book Value / Share 1142.93
ROE % 4.29
ROCE % 5.81
Total Debt to Total Equity 1.98
EBITDA Margin 2.51
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 42.28
Total Assets 1076.32
Total Liabilities 1076.32
Total Equity 456.50
Share Outstanding 30
Price to Book Ratio 2.43
Return on Assets (%) 4.31
Return on Capital (%) 5.12
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 126.80
Total Assets 940.79
Total Liabilities 940.79
Total Equity 408.30
Share Outstanding 30
Price to Book Ratio 3.00
Return on Assets (%) 7.44
Return on Capital (%) 9.09
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 29.01
Total Assets 575.16
Total Liabilities 575.16
Total Equity 155.84
Share Outstanding 22
Price to Book Ratio 0.00
Return on Assets (%) 7.66
Return on Capital (%) 10.73
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 13.89
Total Assets 392.29
Total Liabilities 392.29
Total Equity 103.07
Share Outstanding 22
Price to Book Ratio 0.00
Return on Assets (%) 6.17
Return on Capital (%) 8.75
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 4.18
Total Assets 354.79
Total Liabilities 354.79
Total Equity 69.92
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 2.52
Return on Capital (%) 3.92
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 39.20
Total Assets 973.99
Total Liabilities 973.99
Total Equity 404.36
Share Outstanding 30
Price to Book Ratio 2.43
Return on Assets (%) 4.27
Return on Capital (%) 5.09
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 123.50
Total Assets 851.13
Total Liabilities 851.13
Total Equity 365.17
Share Outstanding 30
Price to Book Ratio 3.00
Return on Assets (%) 7.37
Return on Capital (%) 9.06
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 23.03
Total Assets 500.03
Total Liabilities 500.03
Total Equity 121.63
Share Outstanding 22
Price to Book Ratio 0.00
Return on Assets (%) 7.88
Return on Capital (%) 11.13
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 8.10
Total Assets 329.07
Total Liabilities 329.07
Total Equity 82.28
Share Outstanding 22
Price to Book Ratio 0.00
Return on Assets (%) 6.02
Return on Capital (%) 8.16
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.07
Total Assets 288.38
Total Liabilities 288.38
Total Equity 62.86
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 1.59
Return on Capital (%) 2.44
Particulars MAR 2025 (Values in Cr)
Net Income 60.26
Cash from Operations -108.64
Cash from Investing -34.98
Cash from Financing 55.55
Net change in Cash -91.36
Free Cash Flow -88.60
Particulars MAR 2024 (Values in Cr)
Net Income 87.45
Cash from Operations -124.38
Cash from Investing -47.59
Cash from Financing 265.89
Net change in Cash 67.89
Free Cash Flow -108.76
Particulars MAR 2023 (Values in Cr)
Net Income 65.94
Cash from Operations -45.19
Cash from Investing -3.32
Cash from Financing 74.66
Net change in Cash 15.01
Free Cash Flow -36.98
Particulars MAR 2022 (Values in Cr)
Net Income 35.98
Cash from Operations 10.55
Cash from Investing -11.47
Cash from Financing 14.99
Net change in Cash 8.38
Free Cash Flow 17.06
Particulars MAR 2021 (Values in Cr)
Net Income 15.45
Cash from Operations 6.37
Cash from Investing -13.61
Cash from Financing 13.48
Net change in Cash 1.66
Free Cash Flow 17.05
Particulars MAR 2025 (Values in Cr)
Net Income 52.58
Cash from Operations -129.75
Cash from Investing -18.01
Cash from Financing 59.65
Net change in Cash -90.74
Free Cash Flow -124.17
Particulars MAR 2024 (Values in Cr)
Net Income 71.64
Cash from Operations -118.66
Cash from Investing -46.24
Cash from Financing 258.05
Net change in Cash 70.56
Free Cash Flow -105.77
Particulars MAR 2023 (Values in Cr)
Net Income 55.09
Cash from Operations -38.27
Cash from Investing 0.71
Cash from Financing 61.11
Net change in Cash 14.87
Free Cash Flow -34.95
Particulars MAR 2022 (Values in Cr)
Net Income 28.19
Cash from Operations -12.96
Cash from Investing -7.24
Cash from Financing 27.25
Net change in Cash 4.70
Free Cash Flow -10.60
Particulars MAR 2021 (Values in Cr)
Net Income 6.05
Cash from Operations 1.95
Cash from Investing -5.41
Cash from Financing 8.05
Net change in Cash 0.30
Free Cash Flow 7.36
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
BRITANNIA INDUSTRIES LTD 5810.75 57.95 37.48 139962.55 5300.00 6336.95
NESTLE INDIA LTD. 1476.05 83.53 55.19 284628.84 1085.00 1492.45
FOODS & INNS LTD. 63.96 15.12 0.86 470.31 45.00 128.79
HINDUSTAN UNILEVER LTD. 2272.80 48.90 10.95 534015.10 2023.05 2734.31
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
BRITANNIA INDUSTRIES LTD 5810.75 57.52 42.82 139962.55 5300.00 6336.95
COLGATE PALMOLIVE LTD. 2166.85 44.20 37.24 58935.21 1781.60 2745.95
NESTLE INDIA LTD. 1476.05 82.46 53.61 284628.84 1085.00 1492.45
FOODS & INNS LTD. 63.96 13.35 0.85 470.31 45.00 128.79

MUKKA PROTEINS LIMITED shareholding pattern

Holding
24.97%
73.33%
1.69%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

MUKKA PROTEINS LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
24.63 0.16 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 24.30
  • 26 Days 23.40
  • 10 Days 24.10
  • 50 Days 23.10
  • 12 Days 24.00
  • 100 Days 23.50
  • 20 Days 23.60
  • 200 Days 25.40
24.57 PIVOT
First Support 24.26 First Resistance 24.91 Second Support 23.92 Second Resistance 25.22 Third Support 23.61 Third Resistance 25.56
RSI 63.60 ADX 29.76 MACD 0.61 Williams % R -23.24 Commodity Channel Index (CCI) 88.27
Date 2026-05-07 Week 92506.00 Same Day 119372.00 Month 148849.00
1 Year 0.90 3 Year 0.95
Over 1 Month
14.90% down
Over 1 Year
-18.41% down
Over 3 Months
-0.92% down
Over 3 Years
-16.50% down
Over 6 Months
1.36% down
Over 5 Years
0.00% down

MUKKA PROTEINS LIMITED Corporate Actions

Top Gainers

Top Losers

MUKKA PROTEINS LIMITED Share Price

Mukka Proteins Limited was originally incorporated as 'Mukka Sea Food Industries', a Partnership firm in Karnataka on March 13, 2003. Subsequently, the Partnership Firm was thereafter converted to Private Company as 'Mukka Sea Food Industries Private Limited' on November 04, 2010. The Company subsequently got converted into Public Limited Company dated December 02, 2019 in the name of 'Mukka Sea Food Industries Limited' and the name of the Company changed to 'Mukka Proteins Limited' vide a fresh certificate of incorporation issued by ROC-Bangalore, dated August 06, 2021.

The Company manufacture fish meal, fish oil and fish soluble paste, an essential ingredient in the manufacturing of aqua feed (for
fish and shrimp), poultry feed (for broiler and layer) and pet food (dog and cat food). Further, fish oil also finds its application in pharmaceutical products (additionally, the EPA-DHA extraction is used as an ingredient in nutraceuticals), soap manufacturing, leather tanneries & paint industries.

Led by the Founder Promoter, Mr. Kalandan Mohammed Haris, Mukka Group is one of the pioneers in the Fishmeal Industry having set up one of India's first steam sterilised fishmeal plants. They produce Steam Dried Fish Meal, Fish Oil and Fish Soluble Paste from their modern and fully mechanized plant situated in Karnataka and Gujarat, which is geared up to deliver Fish Meal, Fish Oil and Fish Soluble Paste to every corner of the globe. Recently, the Company diversified products by developing alternative proteins such as Black Soldier Fly (BSF) Insect Meal and Insect Oil in the animal food industry.

The Company business is extended to manufacture of High-Quality Fish Meal and Omega-3 Fish Oil which is used as a raw material in aquafeed, poultry feed, pet feed, animal feed, EPA-DHA extraction (use in nutraceuticals - nutrients plus pharmaceuticals), soap manufacture, leather tanneries & Paint industries across globally.

In 2014, the Company commenced International operations in the Middle East.

In 2018, it set up a Manufacturing Facility in Gujarat.

The Company has raised money from public through IPO aggregating to Rs 224 Crore and by issuing 8,00,00,000 Equity Shares through Fresh Issue on March 4, 2024.

Parent organization Indian Private
NSE symbol MUKKA
Founded 2010
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Mukka Proteins Ltd?

Answer Field

Mukka Proteins Ltd share price is for NSE ₹ 24.70 & for BSE ₹ 24.72 as on May 08 2026 03:29 PM.

What is the Market Cap of Mukka Proteins Ltd Share?

Answer Field

The market cap of Mukka Proteins Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on May 08 2026 03:29 PM.

What is the 52 Week High and Low of Mukka Proteins Ltd?

Answer Field

The 52 Week High and Low of Mukka Proteins Ltd for NSE is ₹ 32.80 and ₹ 18.27 and for BSE is ₹ 32.79 and ₹ 18.32.

What is 1 year return for Mukka Proteins Ltd?

Answer Field

The 1 year returns on the stock has been -18.41%.

What is the P/E Ratio of Mukka Proteins Ltd Share?

Answer Field

As on May 08 2026 03:29 PM the price-to-earnings (PE) ratio for Mukka Proteins Ltd share is 20.15.

What is the PB ratio of Mukka Proteins Ltd Share?

Answer Field

As on May 08 2026 03:29 PM, the price-to-book (PB) ratio for Mukka Proteins Ltd share is 13.64.

How to Buy Mukka Proteins Ltd Share?

Answer Field

You can trade in Mukka Proteins Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Mukka Proteins Ltd Share on Bajaj Broking App?

Answer Field

To buy Mukka Proteins Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Mukka Proteins Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|